AIRLINK 195.40 Increased By ▲ 3.56 (1.86%)
BOP 10.19 Increased By ▲ 0.32 (3.24%)
CNERGY 7.85 Increased By ▲ 0.18 (2.35%)
FCCL 38.40 Increased By ▲ 0.54 (1.43%)
FFL 15.91 Increased By ▲ 0.15 (0.95%)
FLYNG 25.50 Increased By ▲ 0.19 (0.75%)
HUBC 131.35 Increased By ▲ 1.18 (0.91%)
HUMNL 13.93 Increased By ▲ 0.34 (2.5%)
KEL 4.67 No Change ▼ 0.00 (0%)
KOSM 6.32 Increased By ▲ 0.11 (1.77%)
MLCF 45.35 Increased By ▲ 1.06 (2.39%)
OGDC 210.60 Increased By ▲ 3.73 (1.8%)
PACE 6.69 Increased By ▲ 0.13 (1.98%)
PAEL 41.33 Increased By ▲ 0.78 (1.92%)
PIAHCLA 17.83 Increased By ▲ 0.24 (1.36%)
PIBTL 8.12 Increased By ▲ 0.05 (0.62%)
POWER 9.35 Increased By ▲ 0.11 (1.19%)
PPL 181.51 Increased By ▲ 2.95 (1.65%)
PRL 40.35 Increased By ▲ 1.27 (3.25%)
PTC 24.60 Increased By ▲ 0.46 (1.91%)
SEARL 111.20 Increased By ▲ 3.35 (3.11%)
SILK 0.98 Increased By ▲ 0.01 (1.03%)
SSGC 38.60 Decreased By ▼ -0.51 (-1.3%)
SYM 19.18 Increased By ▲ 0.06 (0.31%)
TELE 8.70 Increased By ▲ 0.10 (1.16%)
TPLP 12.43 Increased By ▲ 0.06 (0.49%)
TRG 66.40 Increased By ▲ 0.39 (0.59%)
WAVESAPP 12.51 Decreased By ▼ -0.27 (-2.11%)
WTL 1.69 Decreased By ▼ -0.01 (-0.59%)
YOUW 3.94 Decreased By ▼ -0.01 (-0.25%)
BR100 12,079 Increased By 148.7 (1.25%)
BR30 36,124 Increased By 464.7 (1.3%)
KSE100 114,739 Increased By 1532.2 (1.35%)
KSE30 36,064 Increased By 498.4 (1.4%)
Business & Finance

Moderna to deliver 25 million COVID-19 vaccine doses to Australia

  • It has been trying to speed up the rollout of jabs after it was stalled by supply hold-ups in Europe and concerns about blood clots tied to the AstraZeneca shot.
  • The deal also includes the supply of 15 million doses of Moderna's updated variant booster vaccine candidate to be delivered in 2022, the company said.
Published May 12, 2021

Moderna Inc will supply Australia 25 million doses of its COVID-19 vaccine, of which 10 million doses against the original strain of the virus will be delivered this year, the drugmaker said on Wednesday.

Australia currently has two authorized vaccines from Pfizer-BioNTech and AstraZeneca.

It has been trying to speed up the rollout of jabs after it was stalled by supply hold-ups in Europe and concerns about blood clots tied to the AstraZeneca shot.

The deal also includes the supply of 15 million doses of Moderna's updated variant booster vaccine candidate to be delivered in 2022, the company said.

The pact with Moderna is subject to regulatory approval of its vaccine candidate, which is authorized for emergency use in individuals 18 years of age or older in the United States.

Moderna has also received authorization for its vaccine from health agencies including Canada, Israel, the European Union, the United Kingdom and Switzerland.

Comments

Comments are closed.